tiprankstipranks
IGM Biosciences Inc (IGMS)
NASDAQ:IGMS
Holding IGMS?
Track your performance easily

IGM Biosciences (IGMS) Income Statement

312 Followers

IGM Biosciences Income Statement

Last quarter (Q3 2024), IGM Biosciences's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q3, IGM Biosciences's net income was $-61.43M. See IGM Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.15M$ 2.13M$ 1.07M---
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 237.64M$ 265.59M$ 229.03M$ 165.32M$ 83.28M$ 44.50M
Operating Income
$ -234.72M$ -263.46M$ -227.96M$ -165.32M$ -83.28M$ -44.50M
Net Non Operating Interest Income Expense
$ 15.12M$ 17.74M$ 7.04M$ 159.00K--
Other Income Expense
$ -828.00K$ -20.00K$ -181.00K$ -159.00K$ -1.93M$ -1.36M
Pretax Income
$ -219.60M$ -245.74M$ -221.10M$ -165.16M$ -81.36M$ -43.13M
Tax Provision
$ 242.00K$ 678.00K----
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -219.84M$ -246.42M$ -221.10M$ -165.16M$ -81.36M$ -43.13M
Basic EPS
$ -3.54$ -4.71$ -5.32$ -4.93$ -2.65$ -4.80
Diluted EPS
$ -3.54$ -4.71$ -5.32$ -4.93$ -2.65$ -4.80
Basic Average Shares
$ 241.28M$ 52.31M$ 41.54M$ 33.48M$ 30.75M$ 9.00M
Diluted Average Shares
$ 241.28M$ 52.31M$ 41.54M$ 33.48M$ 30.75M$ 9.00M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 237.64M$ 265.59M$ 229.03M$ 165.32M$ 83.28M$ 44.50M
Net Income From Continuing And Discontinued Operation
$ -219.84M$ -246.42M$ -221.10M$ -165.16M$ -81.36M$ -43.13M
Normalized Income
$ -138.30M$ -190.13M----
Interest Expense
------
EBIT
$ -228.31M$ -263.46M$ -227.96M$ -165.32M$ -83.28M$ -43.13M
EBITDA
$ -217.10M$ -255.18M$ -221.88M$ -160.84M$ -82.25M$ -42.84M
Currency in USD

IGM Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis